ARIALYS THERAPEUTICS
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience. The company focuses on how the immune system impacts CNS health, disease, and treatment.
ARIALYS THERAPEUTICS
Industry:
Health Care Medical Therapeutics
Founded:
2022-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.arialysrx.com
Total Employee:
11+
Status:
Active
Total Funding:
58 M USD
Technology used in webpage:
CrUX Top 50m CrUX Dataset Vimeo
Similar Organizations
Arcus Biosciences
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Intellia Therapeutics
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Mediar Therapeutics
Mediar is a preclinical stage biotechnology company developing therapeutics to halt, or even reverse, fibrosis.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Mitsuyuki Matsumoto Scientific Founder and Chief Scientific Officer @ Arialys Therapeutics
Scientific Founder and Chief Scientific Officer
2022-07-01
Founder
Investors List
MPM Capital
MPM Capital investment in Seed Round - Arialys Therapeutics
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Seed Round - Arialys Therapeutics
Avalon BioVentures
Avalon BioVentures investment in Seed Round - Arialys Therapeutics
Catalys Pacific
Catalys Pacific investment in Seed Round - Arialys Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Seed Round - Arialys Therapeutics
Official Site Inspections
http://www.arialysrx.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.13 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Arialys Therapeutics"
Arialys Therapeutics
Anti-NMDA receptor encephalitis (ANRE) is the most common form of autoimmune encephalitis. ANRE is a potentially lethal, poorly managed and often misdiagnosed neurological disease as …See details»
Team - arialysrx.com
Arialys Therapeutics is a private biotech company founded by Avalon BioVentures, Catalys Pacific, and MPM Capital. Our experienced internal team is focused on clinical evaluation of ART5803 while also partnering with our …See details»
Careers - arialysrx.com
At Arialys, we value diversity and are committed to providing equal employment opportunities. Recruitment agencies may not submit CVs/resumes through the website and are prohibited from contacting our employees directly. We do not …See details»
Arialys - Catalys Pacific
Arialys Therapeutics, Inc. (“Arialys”), a private biotech company founded by Catalys Pacific along with Avalon BioVentures and MPM Capital, is exploring scientific breakthroughs in autoimmune mechanisms to develop new precision …See details»
Arialys Therapeutics - Crunchbase Company Profile
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience. The company focuses on how the immune system impacts CNS health, disease, and treatment.See details»
Arialys Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Nov 1, 2024 Arialys is headquartered in La Jolla, California. For more information, visit www.arialysrx.com . SOURCE: Arialys Therapeutics. ... The statistics for drugs in the Pipeline …See details»
Arialys Therapeutics, Inc. | LinkedIn
Arialys Therapeutics, Inc. Pharmaceutical Manufacturing La Jolla, California 2,082 followers Precision Medicines for Autoimmune Neuropsychiatric DiseasesSee details»
Arialys Therapeutics Company Profile 2024: Valuation, …
Arialys Therapeutics General Information Description. Developer of new precision medicines to specifically block pathogenic autoantibodies in the brain. The company specializes in the field of neuroscience and characterizes the nature …See details»
Arialys Therapeutics
Sep 12, 2023 Arialys is headquartered in the Avalon BioVentures Accelerator on the Torrey Pines Mesa, in La Jolla, California. For more info, visit www.arialysrx.com. Contacts. …See details»
Arialys Therapeutics Appoints Peter Flynn, Ph.D., President
Jun 25, 2024 LA JOLLA, Calif.--(BUSINESS WIRE)-- Arialys Therapeutics, a biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, today …See details»
Arialys Therapeutics Appoints Peter Flynn, Ph.D., President and …
LA JOLLA, Calif., June 25, 2024--Arialys Therapeutics, a biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, today announced the appointment of …See details»
Arialys Therapeutics Launches to Lead the Development of New …
Sep 12, 2023 LA JOLLA, Calif.--(BUSINESS WIRE)-- Arialys Therapeutics, a biotechnology company pioneering new therapeutics for autoimmune neuropsychiatry, today announced the …See details»
Arialys Therapeutics Raises $58M to Target Autoimmune …
Sep 19, 2023 Jay Lichter, PhD President and CEO Arialys Therapeutics. Arialys Therapeutics is seeking to make its mark on the neurological market by developing treatments for autoimmune …See details»
Arialys Therapeutics Announces First Participants Dosed in a Phase …
• ART5803 is being developed for the treatment of anti-NMDAR autoimmune neuropsychiatric diseases, including anti-NMDAR encephalitis (ANRE) • Preclinical data in higher animal …See details»
Arialys Therapeutics
LA JOLLA, Calif., June 25, 2024 – Arialys Therapeutics, a biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, today announced the appointment of …See details»
Arialys Therapeutics Launches to Lead the Development of New …
LA JOLLA, Calif., September 12, 2023--Arialys Therapeutics Launches to Lead the Development of New Precision Medicines for Autoimmune Neuropsychiatric DiseasesSee details»
Arialys Therapeutics Launches to Lead the Development of New …
Sep 12, 2023 Arialys is headquartered in the Avalon BioVentures Accelerator on the Torrey Pines Mesa, in La Jolla, California. For more info, visit www.arialysrx.com. Contacts. …See details»
News & Events - arialysrx.com
Arialys Therapeutics News & Events. Arialys Therapeutics Announces First Participants Dosed in a Phase 1 Clinical Trial of ART5803, a Precision Medicine for the Treatment of Autoimmune …See details»
Arialys Therapeutics Launches to Lead the Development of New …
Sep 12, 2023 Arialys was founded on the breakthrough understanding that immune cells – not only in the body’s periphery but especially in the brain – can produce autoantibodies that …See details»
Arialys Therapeutics Launches to Lead the Development of New …
Sep 12, 2023 LA JOLLA, Calif.--(BUSINESS WIRE)--Arialys Therapeutics, a biotechnology company pioneering new therapeutics for autoimmune neuropsychiatry, today announced the …See details»